Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
NovaFerrum is a pharmaceutical brand and company, operated by Gensavis Pharmaceuticals, that specializes in the development of advanced iron supplements for the treatment of iron deficiency and iron deficiency anemia. The company is best known for its polysaccharide-iron complex (PIC) formulations, which are designed to provide high elemental iron content with improved gastrointestinal tolerability and palatability compared to traditional iron salts. Their product line includes specialized liquid formulations for infants and children, as well as high-dose capsules for adults and prenatal care. NovaFerrum distinguishes itself in the market by offering products that are free from common allergens and additives such as sugar, alcohol, dyes, and gluten. The company's mission focuses on improving patient compliance and clinical outcomes through better-tolerated oral iron therapy.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Novaferrum.